David Lambeth

Corporate Officer/Principal bei Emory University School of Medicine

Consumer Services

Health Technology

Aktive Positionen von David Lambeth

Unternehmen	Position	Beginn	Ende
Emory University School of Medicine	Corporate Officer/Principal	01.01.1980	-

Unternehmen	Position	Beginn	Ende
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Gründer	01.01.2006	-

Duke University

Doctorate Degree

International

Vereinigte Staaten	3
Schweiz	2

Operativ

Founder	1
Doctorate Degree	1
Corporate Officer/Principal	1

Sektoral

Consumer Services	3
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Health Technology

Private Unternehmen

Health Technology